tbuckley/cabot-search huggingface dataset:
Effect of hepatitis B virus treatment on all causes and liver-related death among patients living with HBV with cirrhosis in British Columbia in a population-based cohort study
Authors: Makuza Jean Damascene, Dahn Jeong, Mawuena Binka, Prince Adu, Georgine Cua, Hector Velasquez, Amanda Yu, Stanley Wong, Maria Alvarez, Sofia Bartlett, Alnoor Ramji, Hin HIn Ko, Eric Yoshida, Mel Krajden, Naveed Janjua
Journal: Journal of Hepatology (2022)
Evaluation of immune response and disease flares in metobolic-associated fatty liver disease patients following SARS-CoV-2 vaccination: a prospective cohort study
Authors: Junping Shi, Qianru Zhu, Jin Gao, Jiaping Gu, Lu Shen, Jing Liu, Yu Song, Xiying Gong, Yutong Chen, Jie Liao, Yining He, Siyi Zhang, Li Shao, Yee Hui Yeo, Jie Li
Journal: Journal of Hepatology (2022)
Diagnostic performance of non-invasive liver fibrosis biomarkers: a bayesian individual patient data meta-analysis of hepatitis B cohorts in sub-saharan Africa (HEPSANET)
Authors: Alexander Stockdale, Asgeir Johannessen, Marc Henrion, Edith Okeke, Moussa Seydi, Gilles Wandeler, Mark Sonderup, Wendy Spearman, Michael Vinikoor, Edford Sinkala, Hailemichael Desalegn, Fatou Fall, Nicholas Riches, Davwar Pantong Mark, Mary John Duguru, Tongai Gibson Maponga, Jantjie Taljaard, Philippa Matthews, Monique Andersson, Roger Sombie, Yusuke Shimakawa, Maud Lemoine
Journal: Journal of Hepatology (2022)
Safety, pharmacokinetics, and antiviral activity of the class II capsid assembly modulator ALG-000184 in subjects with chronic hepatitis B
Authors: Man-Fung Yuen, Kosh Agarwal, Edward J Gane, Alina Jucov, Christian Schwabe, Junqi Niu, Jinlin Hou, Kha Le, Benedetta Massetto, Christopher Westland, Qingling Zhang, Felix Lai, Meenakshi Venkatraman, Lawrence Blatt, Tse-I Lin, Sushmita Chanda, Matt McClure, John Fry
Journal: Journal of Hepatology (2022)
Stool microbiota, compared to salivary microbiota, show more extensive correlations with plasma metabolites in decompensated cirrhosis in a multinational cirrhosis cohort
Authors: I.Jan Cox, Marcela Peña Rodríguez, Andrew Fagan, Mayra Rojas Lara, Adrien Le Guennec, Fatima Rodrigez-Alvarez, Sara McGeorge, Ivvone Escalona Nandez, Aldo Torre, Jasmohan S Bajaj
Journal: Journal of Hepatology (2022)
Management of pouch neoplasia: consensus guidelines from the International Ileal Pouch Consortium
Authors: Ravi P Kiran, Gursimran S Kochhar, Revital Kariv, Douglas K Rex, Akira Sugita, David T Rubin, Udayakumar Navaneethan, Tracy L Hull, Huaibin Mabel Ko, Xiuli Liu, Lisa A Kachnic, Scott Strong, Marietta Iacucci, Willem Bemelman, Philip Fleshner, Rachael A Safyan, Paulo G Kotze, André D'Hoore, Omar Faiz, Simon Lo, Jean H Ashburn, Antonino Spinelli, Charles N Bernstein, Sunanda V Kane, Raymond K Cross, Jason Schairer, James T McCormick, Francis A Farraye, Shannon Chang, Ellen J Scherl, David A Schwartz, David H Bruining, Jessica Philpott, Stuart Bentley-Hibbert, Dino Tarabar, Sandra El-Hachem, William J Sandborn, Mark S Silverberg, Darrell S Pardi, James M Church, Bo Shen
Journal: The Lancet. Gastroenterology & hepatology (2022)
Increased burden of inherited IRF3 rare genetic variants in Europeans with severe Non-alcoholic fatty liver diease
Authors: Luigi Santoro, Daniele Marchelli, Alessandro Cherubini, Elia Casirati, Francesco Malvestiti, Melissa Tomasi, Paola Dongiovanni, Cristiana Bianco, Marica Meroni, Alessandro Federico, Salvatore Petta, Elisabetta Bugianesi, Giorgio Soardo, Umberto Vespasiani Gentilucci, Luca Miele, Helen Reeves, Daniele Prati, Luisa Ronzoni, Giodo Baselli, Luca Valenti
Journal: Journal of Hepatology (2022)
Multiple doses of thyroid hormone receptor-beta agonist TERN-501 were well-tolerated and resulted in significant dose-dependent changes in serum lipids and sex hormone binding globulin in a first-in-human clinical study
Authors: Cara H. Nelson, Christopher Jones, Lois Lee, Tonya Marmon, Diana Chung, Kevin Klucher, Yizhao Li, Erin Quirk, Daria Crittenden
Journal: Journal of Hepatology (2022)
Semaglutide 2.4 mg once weekly improved liver and metabolic parameters, and was well tolerated, in patients with non-alcoholic steatohepatitis-related cirrhosis: a randomised, placebo-controlled phase 2 trial
Authors: Rohit Loomba, Manal F. Abdelmalek, Matthew Armstrong, Maximilian Jara, Mette Kjaer, Niels Krarup, Eric Lawitz, Vlad Ratziu, Arun Sanyal, Jörn Schattenberg, Philip N. Newsome
Journal: Journal of Hepatology (2022)
In vivo functional genetic screen with a pooled-shRNA library for therapeutic targets of non-alcoholic fatty liver disease
Authors: Yong-An Lee, Chee Chong Lek, Amanpreet Kaur, Rong Gao, Agnes Bee Leng Ong, Yee Siang Lim, Shirleen Soh, Winston Chan, Yock Young Dan, Huck Hui Ng, Torsten Wuestefeld
Journal: Journal of Hepatology (2022)
Could a multi-target blood test make hepatocellular carcinoma surveillance programs more effective? A modelling-based virtual trial
Authors: Jagpreet Chhatwal, Sumeyye Samur, Ju Dong Yang, Lewis Roberts, Mindie Nguyen, A.Bura Ozbay, Turgay Ayer, Neehar D. Parikh, Amit Singal
Journal: Journal of Hepatology (2022)
Hepatocyte-specific deletiton of the anti-apoptotic Mcl-1 in mice induces polyploidization, mitotic erros and chromosomal instability.
Authors: Laure-Alix Clerbaux, Pierre Cordier, Nina Desboeufs, Kristian Unger, Gabriel Semere, Lap Kwan Chan, Chantal Desdouets, Massimo Lopes, Achim Weber
Journal: Journal of Hepatology (2022)
Liver toxicities of immune checkpoints inhibitors for cancer: a multicenter retrospective study
Authors: Lucia Parlati, Mehdi Sakka, Agnès Bellanger, Jean François Meritet, Samir Bouam, Aurelia Retbi, Pierre Rufat, Dominique Bonnefont-Rousselot, Rui Batista, Patrick Tilleul, Dominique Thabut, Jean-Philippe Spano, Francois Goldwasser, Philippe Sogni, Stanislas Pol, Vincent Mallet
Journal: Journal of Hepatology (2022)
Ibrutinib, rituximab, and lenalidomide in unfit or frail patients aged 75 years or older with de novo diffuse large B-cell lymphoma: a phase 2, single-arm study
Authors: Peng-Peng Xu, Zi-Yang Shi, Ying Qian, Shu Cheng, Yue Zhu, Lu Jiang, Jian-Feng Li, Hai Fang, Heng-Ye Huang, Hong-Mei Yi, Bin-Sheng Ouyang, Li Wang, Wei-Li Zhao
Journal: The Lancet Healthy Longevity (2022)
Hepatitis C virus (HCV)-specific T cell confer resistance to HCV re-infection after sustained virologic response in a non-cytolytic fashion among people who inject drugs: results from ANCHOR study
Authors: Arshi Khanam, Alip Ghosh, Sarah Kattakuzhy, Shyamasundaran Kottilil, Elana Rosenthal
Journal: Journal of Hepatology (2022)
Comparison of on-treatment ALT or FIB-4 as an on-treatment biomarker of hepatitis B treatment for liver cirrhosis patients
Authors: Joo Hyun Oh, Dong Hyun Sinn, Sang Bong Ahn, Wonseok Kang, Geum-Yon Gwak, Yong-Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik
Journal: Journal of Hepatology (2022)
A national study of 23 major trauma centres to investigate the effect of frailty on clinical outcomes in older people admitted with serious injury in England (FiTR 1): a multicentre observational study
Authors: Ben Carter, Roxanna Short, Omar Bouamra, Frances Parry, David Shipway, Julian Thompson, Mark Baxter, Fiona Lecky, Philip Braude
Journal: The Lancet Healthy Longevity (2022)

BackgroundOlder people are the largest group admitted to hospital with serious injuries. Many older people are living with frailty, a risk factor for poor recovery. We aimed to examine the effect of preinjury frailty on outcomes.MethodsIn this multicentre observational study (FiTR 1), we extracted prospectively collected data from all 23 adult major trauma centres in England on older people (aged ≥65 years) admitted with serious injuries over a 2·5 year period from the Trauma Audit and Research Network (TARN) database. Geriatricians assessed the preinjury Clinical Frailty Scale (CFS), a 9-point scale of fitness and frailty, with a score of 1 indicating a patient is very fit and a score of 9 indicating they are terminally ill. The primary outcome was inpatient mortality, with patients censored at hospital discharge. We used a multi-level Cox regression model fitted with adjusted hazards ratios (aHRs) to assess the association between CFS and mortality, with CFS scores being grouped as follows: a score of 1–2 indicated patients were fit; a score of 3 indicated patients were managing well; and a score of 4–8 indicated patients were living with frailty (4 being very mild, 5 being mild, 6 being moderate, and 7–8 being severe).FindingsBetween March 31, 2019, and Oct 31, 2021, 193 156 patients had records were held by TARN, of whom 16 504 had eligible records. Median age was 81·9 years (IQR 74·7–88·0), 9200 (55·7%) were women, and 7304 (44·3%) were men. Of 16 438 patients with a CFS score of 1–8, 11 114 (67·6%) were living with frailty (CFS of 4–8). 1660 (10·1%) patients died during their hospital stay, with a median time from admission to death of 9 days (IQR 4–18). Compared in patients with a CFS score of 1–2, risk of inpatient death was increased in those managing well (CFS score of 3; aHR 1·82 [95% CI 1·39–2·40]), living with very mild frailty (CFS score of 4: 1·99 [1·51–2·62]), living with mild frailty (CFS score of 5: 2·61 [1·99–3·43]), living with moderate frailty (CFS score of 6: 2·97 [2·26–3·90]), and living with severe frailty (CFS score of 7–8: 4·03 [3·04–5·34]).InterpretationOur findings support inclusion of the CFS in trauma pathways to aid patient management. Additionally, people who exercise regularly (CFS of 1–2) have better outcomes than those with lower activity levels (CFS of ≥3), supporting exercise as an intervention to improve trauma outcomes.FundingNone.
A prospective trial of a gluten free diet in primary sclerosing cholangitis with associated colitis
Authors: Timur Liwinski, Sina Hübener, Lara Henze, Peter Huebener, Melina Heinemann, Bettina Jagemann, Marcus Tetzlaff, Guido Schachschal, Thomas Rösch, Erika Monguzzi, Corinna Bang, Andre Franke, Ansgar W. Lohse, Detlef Schuppan, Christoph Schramm
Journal: Journal of Hepatology (2022)
Cholangiocarcinoma landscape in Europe: diagnostic, prognostic and therapeutic insights from the ENSCCA Registry
Authors: Laura Izquierdo-Sánchez, Angela Lamarca, Adelaida La Casta, Stefan Buettner, Kirsten Utpatel, Heinz-Josef Klümpen, Jorge Adeva, Arndt Vogel, Ana Lleo, Luca Fabris, Mariano Ponz-Sarvise, Brustia Raffaele, Vincenzo Cardinale, Chiara Braconi, Gianpaolo Vidili, Nigel B. Jamieson, Rocio IR Macias, Philipp Jonas, Marco Marzioni, Wacław Hołówko, Trine Folseraas, Juozas Kupcinskas, Zeno Sparchez, Marcin Krawczyk, Łukasz Krupa, Viorel Scripcariu, Gianluca Grazi, Ana Landa-Magdalena, Jan Ijzermans, Katja Evert, Joris Erdmann, Flora López-López, Anna Saborowski, Alexander Scheiter, Alvaro Santos-Laso, Guido Carpino, Jesper Andersen, Jose Marin, Domenico Alvaro, Luis Bujanda, Alejandro Forner, Juan Valle, Bas Groot Koerkamp, Jesus Maria Banales
Journal: Journal of Hepatology (2022)
Diagnostic accuracy of non-invasive tests for fibrotic NASH-An individual participant data meta-analysis
Authors: Ferenc Mozes, Jenny Lee, Yasaman Vali, Emmanuel Selvaraj, Arjun Jayaswal, Jerome Boursier, Elisabetta Bugianesi, Ramy Younes, Monica Lupsor-Platon, Salvatore Petta, Toshihide Shima, Takeshi Okanoue, Sanjiv Mahadeva, Wah-Kheong Chan, Gideon Hirschfield, Peter Eddowes, Philip N. Newsome, Vincent Wai-Sun Wong, Victor de Lédinghen, Jeremy Cobbold, Yoshio Sumida, Akira Okajima, Jörn Schattenberg, Christian Labenz, Won Kim, Myoung Seok Lee, Guruprasad Aithal, Naaventhan Palaniyappan, Cristophe Cassinotto, Sandeep Aggarwal, Harshit Garg, Geraldine Ooi, Atsushi Nakajima, Masato Yoneda, Ming-Hua Zheng, Céline Fournier, Michael Trauner, Andreas Geier, Theresa Tuthill, Carla Yunis, Quentin Anstee, Stephen Harrison, Patrick Bossuyt, Michael Pavlides
Journal: Journal of Hepatology (2022)
HCV-RNA viral load fingerstick assay as a simplified strategy for screening and linkage to care of people who use drugs attending 3 french addiction centers
Authors: Denis Ouzan, Joris Herin, Nicolas Camerlo, Patrick Favot, Bruno Blasi, Maella Lebrun, Henriette Thiercelin, Nathalie Legros, Teresa Namouni, Perrine Roux, Stéphane Chevaliez
Journal: Journal of Hepatology (2022)
Metabolic associated fatty liver disease is associated with appendicular lean soft tissue abnormalities in patients with chronic hepatitis B
Authors: Cecy Maria de Lima Santos, Matheus Duarte Brito, Olívio Brito Malheiro, Tatiana Bering Bering, Maria Isabel Toulson Davidson Correia, Rosangela Teixeira, Rodrigo Cambraia, Gifone Aguiar Rocha, Luciana Diniz Silva
Journal: Journal of Hepatology (2022)
Detection of notable hepatitis B virus serologic activity after hepatitis B surface antigen seroclearance
Authors: Danny Ka-Ho Wong, Takako Inoue, Lung Yi Loey Mak, Yan Yue James Fung, Ka-Shing Cheung, Wai-Kay Seto, Yasuhito Tanaka, Man-Fung Yuen
Journal: Journal of Hepatology (2022)
Long-term outcomes (beyond 5 years) of liver transplant recipients-a transatlantic multicentre study
Authors: Naaventhan Palaniyappan, Emily Peach, Fiona Pearce, Amritpal Dhaliwal, Isabel Campos-Varela, Matthew Cant, Cristina Dopazo, Sapna Divani-Patel, James F. Trotter, Ayiesha Hatta, Laurence Hopkins, Giuliano Testa, Angela Bilbao, Zain Kasmani, Sarah Faloon, Darius F. Mirza, Goran Klintmalm, Itxarone Bilbao, Sumeet Asrani, Neil Rajoriya, Aloysious Aravinthan
Journal: Journal of Hepatology (2022)
Implication of metabolic associated fatty liver disease and sex differences in the risk of developing liver fibrosis in patients with Hepatitis C
Authors: Martín Uriel Vázquez Medina, Eira Cerda Reyes, Cruz Vargas-De-León, Patty Marlen Ramírez Portillo, Alejandro Gutierrez Atemis, Juan Armendariz-Borunda
Journal: Journal of Hepatology (2022)
An easy to use score to predict survival in patients with hepatocellular carcinoma before the first transarterial chemoembolization session: AFP-DIAM score
Authors: Estelle Rebillard, Benjamin Buchard, Nicolas De Abreu, Mathieu Boulin, Anne Minello Franza, Benoît Magnin, Maud Reymond, Leon Muti, Bruno Pereira, Armand Abergel
Journal: Journal of Hepatology (2022)
Hepatocyte cell-specific deletion of cathepsin D does not affect liver inflammation and fibrosis during cholestatic-induced liver fibrosis
Authors: Maria Fernandez-Fernandez, Paloma Ruiz-Blazquez, Valeria Pistorio, Susana Núñez, M.Carme Garcia-Ruiz, José Fernandez-Checa, Anna Moles
Journal: Journal of Hepatology (2022)
Results of the Non-invasive Biomarkers of Metabolic Liver Disease (NIMBLE) study 1.1 on the reproducibility and repeatability of shear-wave and transient elastography in non-alcoholic fatty liver disease
Authors: Theodore Pierce, Arinc Ozturk, Sarah Sherlock, Guilherme Cunha, Xiaohong Wang, Qian Li, Marian Martin, Hannah Edenbaum, Kathleen Corey, Yesenia Covarrubias, Sudha Shankar, Helen Heymann, Tania Kamphaus, Roberto Calle, Nancy Obuchowski, Arun Sanyal, Rohit Loomba, Claude Sirlin, Kathryn Fowler, Anthony Samir
Journal: Journal of Hepatology (2022)
New cases of Budd-Chiari syndrome and splanchnic vein thrombosis after COVID-19 vaccination-a vascular liver disease group (VALDIG) initiative
Authors: Raoel Maan, Aurélie Plessier, Louise China, David Patch, Anna Baiges, Juan Carlos Garcia Pagan, Virginia Hernandez-Gea, Marie-Noëlle Hilleret, E.T.T.L. Tjwa, Ilias Kounis, Christophe Bureau, Baptiste Giguet, Alexandra Heurgue-Berlot, Isabelle Ollivier-Hourmand, Xavier Causse, Filipe Gaio Castro Nery, Mandy Lauw, Sarwa Darwish Murad
Journal: Journal of Hepatology (2022)
Metabolic NAFLD subtypes align with cardiovascular and genetic risk factors
Authors: Ibon Martínez-Arranz, Chiara Bruzzone, Mazen Noureddin, Rubén Gil-Redondo, Enara Arretxe, Marta Iruarrizaga-Lejarreta, Maider Bizkarguenaga, Itziar Mincholé, David Fernández Ramos, Fernando Lopitz Otsoa, Rebeca Mayo, Nieves Embade, Elizabeth Newberry, Bettina Mittendorf, Laura Izquierdo-Sánchez, Ylenia Pérez Castaño, Vaclav Smid, Jorge Arnold, Marcin Krawczyk, Paula Iruzubieta, Urko M Marigorta, Martine C. Morrison, Robert Kleemann, Antonio Martín Duce, Liat Hayardeny, Libor Vitek, Radan Bruha, Rocío Aller, Javier Crespo, Manuel Romero Gomez, Jesus Maria Banales, Marco Arrese, Kenneth Cusi, Elisabetta Bugianesi, Samuel Klein, Shelly C. Lu, Quentin Anstee, Oscar Millet, Nicholas O Davidson, Cristina Alonso, José M. Mato
Journal: Journal of Hepatology (2022)
Machine learning-enabled continuous scoring of histologic features facilitates prediction of clinical disease progression in patients with non-alcoholic steatohepatitis
Authors: Janani Iyer, Charles Biddle-Snead, Quang Le, Pratik Mistry, Isaac Finberg, Victoria Mountain, Rob Myers, Chuhan Chung, Andrew Billin, Tim Watkins, Ilan Wapinski, Michael Montalto, Andrew Beck, Murray Resnick, Katy Wack
Journal: Journal of Hepatology (2022)
Hepatic inflammation elicits production of proinflammatory netrin-1 through exclusive activation of translation
Authors: Romain Barnault, Claire Verzeroli, Carole Fournier, Michelet Maud, Anna-Rita Redavid, Ievgeniia Chicherova, Marie-Laure Plissonnier, Annie Adrait, Olga Khomich, Fleur Chapus, Mathieu Richaud, Maëva Hervieu, Veronika Reiterer, Federica-Grazia Centonze, Julie Lucifora, Birke Bartosch, Michel Rivoire, Hesso Farhan, Yohann Couté, Valbona Mirakaj, Thomas Decaens, Patrick Mehlen, Benjamin Gibert, Fabien Zoulim, Romain Parent
Journal: Journal of Hepatology (2022)
Effect of smartphone-assisted lifestyle intervention in patients with metabolic-associated fatty liver disease (MAFLD): a preliminary analysis of a randomized controlled trial
Authors: Suraphon Assawasuwannakit, Apichat Kaewdech, Chaitong Churuangsuk, Naichaya Chamroonkul, Pimsiri Sripongpun
Journal: Journal of Hepatology (2022)
Hepatic insulin resistance is the basis of bile acid dysmetabolism in non-alcoholic fatty liver disease
Authors: Sami Qadri, Emilia Vartiainen, Noora Ahlholm, Kimmo Porthan, Anne Juuti, Henna Sammalkorpi, Anne Penttilä, Johanna Arola, Taru Tukiainen, Matej Orešič, Tuulia Hyötyläinen, Hannele Yki-Järvinen
Journal: Journal of Hepatology (2022)
Antinucleocapsid Antibodies After SARS-CoV-2 Infection in the Blinded Phase of the Randomized, Placebo-Controlled mRNA-1273 COVID-19 Vaccine Efficacy Clinical Trial
Authors: Dean Follmann, Holly E. Janes, Olive D. Buhule, Honghong Zhou, Bethany Girard, Kristen Marks, Karen Kotloff, Michaël Desjardins, Lawrence Corey, Kathleen M. Neuzil, Jacqueline M. Miller, Hana M. El Sahly, Lindsey R. Baden
Journal: Annals of Internal Medicine (2022)

Immunoassays for determining past SARS-CoV-2 infection have not been systematically evaluated in vaccinated persons in comparison with unvaccinated persons.
Role of liver biopsy in management of immune checkpoint inhibitors hepatitis: a single-center retrospective study
Authors: Kennie Marcin, Lucia Parlati, Benoit Terris, Clemence Hollande, Anais Vallet Pichard, Helene Fontaine, Marion Cororuge, Loriane Lair Mehiri, Vincent Mallet, Philippe Sogni, Stanislas Pol
Journal: Journal of Hepatology (2022)
JAM-A is a multifaceted regulator in hepatic fibrogenesis, supporting LSEC integrity and stellate cell quiescence
Authors: Jonathan Frederik Brozat, Elisa Brandt, Myriam Stark, Petra Fischer, Theresa Hildegard Wirtz, Alexander Flaßhove, Aaron Nikolai Rodenhausen, Tanja Vajen, Alexandra C.A. Heinzmann, Sophia M. Schmitz, Samira Abu Jhaisha, Anjali A. Röth, Rory R. Koenen, Hacer Sahin, Christian Trautwein, Marie-Luise Berres
Journal: Journal of Hepatology (2022)
EDP-514, a novel pangenotypic class II hepatitis B virus core inhibitor: final results of a 28-day phase 1b study in nuc-suppressed chronic hepatitis B patients
Authors: Jordan Feld, Eric Lawitz, Tuan T Nguyen, Jacob P Lalezari, Tarek Hassanein, Paul Martin, Steven-Huy B Han, Douglas T Dieterich, Jeanne-Marie Giard, Guy De La Rosa, Alaa Ahmad, Ed Luo, Annie Conery, Nathalie Adda
Journal: Journal of Hepatology (2022)
Novel imaging feature in patients with porto-sinusoidal vascular disorder (PSVD)-radiological evaluation guiding diagnosis
Authors: Georg Semmler, Katharina Lampichler, Katharina Wöran, Benedikt Simbrunner, Mathias Jachs, Lukas Hartl, David J.M Bauer, Lorenz Balcar, Matthias Pinter, Michael Trauner, Mattias Mandorfer, Dietmar Tamandl, Judith Stift, Ahmed Ba-Ssalamah, Thomas Reiberger, Martina Scharitzer, Bernhard Scheiner
Journal: Journal of Hepatology (2022)
Clinicians’ perspectives on barriers and facilitators for the adoption of non-invasive liver tests: a mixed-method study
Authors: Yasaman Vali, Roel Eijk, Timothy Hicks, Will Jones, Jana Suklan, Vlad Ratziu, Adriaan G. Holleboom, Miranda Langendam, Quentin Anstee, Patrick Bossuyt
Journal: Journal of Hepatology (2022)
Changes in hepatic parameters, growth, sleep, and biochemical markers with odevixibat treatment across patients with various types of progressive familial intrahepatic cholestasis
Authors: Lorenzo D’Antiga, Girish Gupte, Richard J. Thompson, Ekkehard Sturm, Pier Luigi Calvo, Mohammad Ali Shagrani, Janis M. Stoll, Reha Artan, Buket Dalgıç, Hasan Ozen, Kathleen M. Loomes, Jennifer M. Vittorio, Saul J. Karpen, Angelo Di Giorgio, Quanhong Ni, Lise Kjems, Patrick Horn
Journal: Journal of Hepatology (2022)
Reproducibility and applicability of spleen stiffness measurement by vibration controlled transient elastograghy in patients with and without chronic liver disease
Authors: Cristina Rigamonti, Micol Cittone, Giulia Francesca Manfredi, Andrea Sorge, Riccardo Moia, Maria Francesca Donato, Gianluca Gaidano, Mirella Fraquelli
Journal: Journal of Hepatology (2022)
Natural history of hepatic steatosis associated to metabolic syndrome. Longitudinal study with 5 years of follow-up.
Authors: Marta Cervera, Marta Carol, Ana Belén Rubio, Martina Perez, Carlota Riba, Rosario Hernández, Ann Ma, Emma Avitabile, Anna Soria, Octavi Bassegoda, Sara Martinez, Jordi Gratacós-Gines, Adria Juanola, Laura Napoleone, Elisa Pose, Isabel Graupera, Pere Ginès, Núria Fabrellas
Journal: Journal of Hepatology (2022)
Diagnostic accuracy of protein-induced by vitamin K absence (PIVKA-II) for hepatocellular carcinoma (HCC) among caucasian cirrhotic patients with or without diagnostic serum a-fetoprotein (AFP) levels
Authors: Antonia Syriha, Dionysia Mandilara, Spyridon Pantzios, Ioanna Stathopoulou, Georgia Barla, Petros Galanis, Ioannis Elefsiniotis
Journal: Journal of Hepatology (2022)
Use of machine learning to predict the histopathological ImmunoScore in hepatocellular carcinoma on multiparametric MRI
Authors: Junlin Yang, Annabella Shewarega, Jessica Santana, Vasily Pekurovsky, Xuchen Zhang, MingDe Lin, David Madoff, Lawrence Staib, Julius Chapiro, James Duncan
Journal: Journal of Hepatology (2022)
Plasma TREM2, a novel non-invasive biomarker for diagnosis of NASH in NAFLD patients with elevated liver stiffness
Authors: Charlotte Wernberg, Vineesh Indira Chandran, Mette Lauridsen, Frederik Larsen, Maria Kløjgaard Skytthe, Camilla Dalby Hansen, Majken Siersbæk, Tina Di Caterino, Sönke Detlefsen, Yaseelan Palarasah, Kim Ravnskjaer, Lars Groentved, Søren Kragh Moestrup, Maja Thiele, Jonas Graversen, Aleksander Krag
Journal: Journal of Hepatology (2022)
Noninvasive prediction of hepatocellular carcinoma development after oral antiviral therapy in patients with chronic hepatitis C: a multicenter study
Authors: Yu Rim Lee, Jung Gil Park, Min Kyu Kang, Jung Eun Song, Byoung Kuk Jang, Young Oh Kweon, Won Young Tak, Se Young Jang, Changhyeong Lee, Byung Seok Kim, Jae-Seok Hwang, Woo Jin Chung, Soo Young Park, Nae-Yun Heo, Jeong Heo, Hyun Young Woo, Yanghyon Baek, Jun Sik Yoon, Joonho Jeong, Jae Young Jang
Journal: Journal of Hepatology (2022)
Therapeutic inhibition of complement component 5 does not reduce NASH progression but does attenuate atherosclerosis development in Ldlr-/-.Leiden mice
Authors: Florine Seidel, Robert Kleemann, Wim van Duyvenvoorde, Nikki van Trigt, Nanda Keijzer, Sandra van der Kooij, Cees van Kooten, Lars Verschuren, Aswin L. Menke, Johnathan Winter, Timothy Hughes, Paul Morgan, Frank Baas, Kees Fluiter, Martine C. Morrison, Amanda Kiliaan
Journal: Journal of Hepatology (2022)